Skip to main content
Premium Trial:

Request an Annual Quote

GE, Hamilton Developing FTA Workflow

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –GE Health and Hamilton Robotics today announced a licensing agreement and collaboration to develop an automated workflow for sample handling and processing from FTA substrates.

The deal focuses on challenges in high-throughput dried sample processing for applications including drug metabolism and pharmacogenetics, and human identification, Richard Dool, GE Healthcare's general manager for consumables, said in a statement. By removing process bottlenecks, his firm and Hamilton hope to "establish a new standard in efficiency and reliability."

Terms of the deal were not disclosed.

According to Radi Hofstetter, vice president of the Hamilton facility in Bonaduz, Switzerland, FTA paper is becoming the method of choice in forensic sample collection, processing, and storage. "Incorporating this technology into an automated workflow will afford higher throughput and efficiencies within forensics as well as in new areas of application, including" drug metabolism and pharmacogenetics, he said.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.